Table 5.
Baseline characteristics in excluded patients.
| Parameter | CABG group n = 156 |
LVAD group n = 389 |
p-value |
|---|---|---|---|
| Age (years)a | 69.4 ± 9.6 | 58.9 ± 8.6 | <0.001 |
| Sex, maleb | 134 (85.9) | 348 (89.5) | 0.24 |
| Body mass index (kg/m2)a | 27.5 ± 4.4 | 26.6 ± 4.9 | 0.034 |
| Diabetes mellitusb | 81 (51.9) | 130 (33.4) | <0.001 |
| Insulin-dependent diabetes mellitusb | 58 (37.2) | 16 (4.1) | <0.001 |
| Major myocardial infarctionb | 92 (59.0) | 50 (12.9) | <0.001 |
| Mitral regurgitationc,d | 0 (0–1) | 1 (1–2) | <0.001 |
| Cardiac arrestb | 9 (5.8) | 26 (6.7) | 0.85 |
| Renal replacement therapyb | 3 (1.9) | 64 (16.5) | <0.001 |
| Chronic obstructive pulmonary diseaseb | 32 (20.5) | 55 (14.1) | 0.07 |
| Peripheral vascular diseaseb | 31 (19.9) | 57 (14.7) | 0.16 |
| Strokeb | 7 (4.5) | 54 (13.9) | 0.001 |
| Mechanical ventilationb | 7 (4.5) | 201 (20.1) | <0.001 |
| Inotropic supportb | 30 (19.2) | 93 (23.9) | <0.001 |
| Mechanical circulatory supportb | 10 (6.4) | 127 (22.8) | <0.001 |
| MELD-XIc | 12.0 (9.4–14.2) | 15.8 (11.7–20.7) | <0.001 |
CABG, coronary artery bypass grafting; LVAD, left ventricular assist device; MELD-XI, model for end-stage liver disease.
a
mean and standard deviation.
b
number and percentage.
c
median with 25th and 75th percentiles.
d
scale ranging from 0 to 3; abbreviations.